Please use this identifier to cite or link to this item: http://dspace.uniten.edu.my/jspui/handle/123456789/3467
DC FieldValueLanguage
dc.contributor.authorBukhari, S.N.A.en_US
dc.contributor.authorLauro, G.en_US
dc.contributor.authorJantan, I.en_US
dc.contributor.authorChee, C.F.en_US
dc.contributor.authorAmjad, M.W.en_US
dc.contributor.authorBifulco, G.en_US
dc.contributor.authorSher, H.en_US
dc.contributor.authorAbdullah, I.en_US
dc.contributor.authorRahman, N.A.en_US
dc.date.accessioned2017-10-27T00:35:14Z-
dc.date.available2017-10-27T00:35:14Z-
dc.date.issued2016-
dc.description.abstractAim: In present study, the anti-inflammatory activities of a new series of benzimidazole derivatives were studied, investigating their inhibition of secretory phospholipase A2, lipoxygenase, COXs and lipopolysaccharide-induced secretion of TNF-α and IL-6 in mouse RAW264.7 macrophages. Results: Synthesized compounds effectively inhibited proinflammatory enzymes and cytokines. Conclusion: A strong inhibition of secretory phospholipases A2 was exhibited by benzimidazole derivatives with trifluoromethyl and methoxy substitutions at position 4 of attached phenyl, whereas compound 8 containing pyridine ring substituted with amino group showed very potent 5-lipoxygenase inhibition. Molecular docking experiments were carried out to elucidate the molecular basis of the observed inhibitory activities. © 2016 Future Science Ltd.en_US
dc.language.isoenen_US
dc.relation.ispartofFuture Medicinal Chemistry Volume 8, Issue 16, October 2016, Pages 1953-1967en_US
dc.titleAnti-inflammatory trends of new benzimidazole derivativesen_US
dc.typeArticleen_US
dc.identifier.doi10.4155/fmc-2016-0062-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptUniversiti Tenaga Nasional-
Appears in Collections:COE Scholarly Publication
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.